ECSP034703A - COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS - Google Patents

COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS

Info

Publication number
ECSP034703A
ECSP034703A ECSP034703A ECSP034703A EC SP034703 A ECSP034703 A EC SP034703A EC SP034703 A ECSP034703 A EC SP034703A EC SP034703 A ECSP034703 A EC SP034703A
Authority
EC
Ecuador
Prior art keywords
combinations
absorption inhibitor
treatment
vascular conditions
sterol absorption
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Teddy Kosoglou
Rudyard Joseph Ress
John Strony
Enrico P Veltri
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34572580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP034703(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ECSP034703A publication Critical patent/ECSP034703A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona composiciones, , combinaciones terapéuticas y métodos que incluyen: a) al menos un inhibidor de la absorción de esterol; b) al menos un modificador sanguíneo, el cual puede ser útil para tratar cuadros vasculares y para reducir los niveles plasmáticos de esteroles.The present invention provides compositions, therapeutic combinations and methods that include: a) at least one sterol absorption inhibitor; b) at least one blood modifier, which may be useful for treating vascular conditions and for reducing sterile plasma levels.

ECSP034703 2001-01-26 2003-07-24 COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS ECSP034703A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26439601P 2001-01-26 2001-01-26

Publications (1)

Publication Number Publication Date
ECSP034703A true ECSP034703A (en) 2003-09-24

Family

ID=34572580

Family Applications (3)

Application Number Title Priority Date Filing Date
ECSP034703 ECSP034703A (en) 2001-01-26 2003-07-24 COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS
ECSP034704 ECSP034704A (en) 2001-01-26 2003-07-24 INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES
ECSP034702 ECSP034702A (en) 2001-01-26 2003-07-24 COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONS

Family Applications After (2)

Application Number Title Priority Date Filing Date
ECSP034704 ECSP034704A (en) 2001-01-26 2003-07-24 INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES
ECSP034702 ECSP034702A (en) 2001-01-26 2003-07-24 COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONS

Country Status (3)

Country Link
CN (2) CN1915429B (en)
EC (3) ECSP034703A (en)
ZA (2) ZA200305692B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103086938A (en) * 2011-10-28 2013-05-08 沈阳药科大学 Ezetimibe synthesis method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3300B (en) * 1992-12-23 1995-06-26 Schering Corp Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
MX9606319A (en) * 1994-06-20 1997-05-31 Schering Corp Substituted azetidinone compounds useful as hypocholesterolemic agents.
PT1140187E (en) * 1998-12-23 2004-01-30 Searle Llc COMBINATIONS OF AN INHIBITOR OF IBAT AND AN INHIBITOR OF MTP FOR CARDIOVASCULAR INDICATIONS

Also Published As

Publication number Publication date
ECSP034704A (en) 2003-09-24
ZA200305692B (en) 2004-10-25
CN1915429A (en) 2007-02-21
ECSP034702A (en) 2003-09-24
ZA200305694B (en) 2004-10-25
CN101297969B (en) 2011-03-09
CN1915429B (en) 2010-12-15
CN101297969A (en) 2008-11-05

Similar Documents

Publication Publication Date Title
ECSP074704A (en) INHIBITOR COMBINATIONS (S) OF STEROL ABSORPTION WITH BLOOD MODIFIER (S) TO TREAT VASCULAR TABLES
AR032403A1 (en) INHIBITOR COMBINATIONS (ES) OF STEROL ABSORPTION WITH BLOOD MODIFIER (ES) TO TREAT VASCULAR TABLES
NO20041598L (en) Methods for the treatment or prophylaxis of vascular inflammation using sterol absorption inhibitor (s)
ECSP11004702A (en) COMBINATIONS DEACTIVATOR (S) OF THE PEROXISMAL PROLIFERATION ACTIVATION RECEIVER (PPAR) AND STEROL ABSORPTION INHIBITOR (ES) AND TREATMENTS FOR VASCULAR INDICATIONS
CY1106149T1 (en) THE USE OF SUBSTITUTED AZETIDINONE COMPOUNDS FOR THE TREATMENT OF SITOSTEPOLEMIA
WO2005046797A3 (en) Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
TW200744638A (en) Combinations of bile acid sequestrant(s) and sterol absorption inhibitors and treatments for vascular indications
DK1429756T3 (en) Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
EP2281561A3 (en) Use of LCK inhibitors for treatment of immunologic diseases
EA200800755A1 (en) IKK INHIBITORS INTRODUCED FOR THE TREATMENT OF ENDOMETRIOSIS
BRPI0508254A (en) methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents
BRPI0408491A (en) treatment of alzheimer's disease
BR0313413A (en) Use of beta amyloid vaccination together with a selective cox-2 inhibitor for the treatment of alzheimer's disease
ECSP034703A (en) COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS
BRPI0507302A (en) Method and Compositions for the Treatment of Lipodystrophy
EP1859796A3 (en) Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors